v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Aug. 29, 2026
Aug. 30, 2025
Cash flows from operating activities:    
Net income including non-controlling interest $ 168,031 $ 122,342
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:    
Depreciation 73,278 68,314
Amortization 65,182 64,525
Deferred income taxes (15,478) (39,227)
Loss from equity method investments, net of dividends received 1,422 1,045
Loss on the sale of business 0 1,515
Loss on impairment of intangible asset 0 478
Gain on sale or disposal of assets (1,025) (178)
Share-based compensation 20,144 18,170
Pension and other post-retirement plan benefit (18,301) (16,393)
Loss on debt extinguishment and bridge financing fees 6,598 0
Change in assets and liabilities, net of effects of acquisitions:    
Accounts receivable, net (78,868) (3,336)
Inventory (106,440) (42,095)
Other assets (4,825) 2,176
Accounts payable 93,622 (25,764)
Accrued compensation (15,184) (19,230)
Other accrued expenses 21,131 6,856
Income taxes payable (3,409) (12,993)
Pension plan assets and liabilities 1,385 (177)
Other liabilities (5,110) 28,622
Foreign currency remeasurement 189 2,106
Net cash provided by operating activities 182,629 156,756
Cash flows from investing activities:    
Purchased property, plant and equipment (141,653) (94,593)
Purchased businesses, net of cash acquired (3,817) (162,095)
Payment of holdback on acquisitions (11,627) 0
Proceeds from sale of property, plant and equipment 4,638 843
Purchase of cost method investment 0 (2,549)
Proceeds from the sale of a business 0 75,727
Net cash used in investing activities (152,459) (182,667)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 1,643,500 1,114,300
Repayment of long-term debt (1,603,993) (1,053,593)
Payment of debt issuance costs (15,067) (1,047)
Net payment of notes payable 0 (585)
Dividends paid (39,149) (37,559)
Proceeds from stock options exercised 12,177 5,519
Repurchases of common stock (48,862) (60,728)
Net cash used in financing activities (51,394) (33,693)
Effect of exchange rate changes on cash and cash equivalents 11,241 12,710
Net change in cash and cash equivalents (9,983) (46,894)
Cash and cash equivalents at beginning of period 107,213 169,352
Cash and cash equivalents at end of period 97,230 122,458
Foreign Exchange Forward Associated with AMS [Member]    
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:    
Unrealized gain on forward exchange contract related to a pending acquisition $ (19,713) $ 0